CGEM
Cullinan Therapeutics, Inc.Company with tickers: CGEM
Market Cap
$1.13B
Shares Outstanding
61,458,046
CIK
1789972
CUSIP
230031106
13F Activity (30d)
1 filings
1 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
54
Net buyers
-1
Net shares bought
-0.01%
Net buy value
-$116,996
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-16 | Thistle Mary |
Director | Award | 25,319 |
| 2026-06-16 | Webster Stephen W |
Director | Award | 25,319 |
| 2026-06-16 | Meek David D. |
Director | Award | 25,319 |
| 2026-06-16 | Rosenberg Anthony |
Director | Award | 25,319 |
| 2026-06-16 | Allen Andrew R |
Director | Award | 21,781 |
| 2026-06-16 | Doyle Mittie |
Director | Award | 21,781 |
| 2026-05-05 | Michaelson Jennifer |
Chief Scientific Officer | Convert | 4,000 |
| 2026-05-05 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 7,800 |
| 2026-05-05 | Michaelson Jennifer |
Chief Scientific Officer | Convert | 4,000 |
| 2026-05-05 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 200 |
| 2026-03-05 | Michaelson Jennifer |
Chief Scientific Officer | Convert | 4,000 |
| 2026-03-05 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 8,000 |
| 2026-03-05 | Michaelson Jennifer |
Chief Scientific Officer | Convert | 4,000 |
| 2026-02-25 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 1,780 |
| 2026-02-24 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 3,601 |
| 2026-02-24 | SUMER JACQUELYN L |
Chief Legal Officer | Sell | 3,601 |
| 2026-02-24 | AHMED NADIM |
EVP and President, Hematology | Sell | 13,515 |
| 2026-02-24 | Jones Jeffrey Alan |
Chief Medical Officer | Sell | 4,582 |
| 2026-02-23 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 1,752 |
| 2026-02-20 | Fenton Mary Kay |
Chief Financial Officer | Sell | 4,398 |
| 2026-02-20 | SUMER JACQUELYN L |
Chief Legal Officer | Sell | 3,742 |
| 2026-02-20 | Jones Jeffrey Alan |
Chief Medical Officer | Sell | 4,982 |
| 2026-02-20 | AHMED NADIM |
EVP and President, Hematology | Sell | 16,381 |
| 2026-02-20 | Michaelson Jennifer |
Chief Scientific Officer | Convert | 8,000 |
| 2026-02-20 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 3,742 |
| 2026-02-20 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 8,000 |
| 2026-02-20 | Michaelson Jennifer |
Chief Scientific Officer | Convert | 8,000 |
| 2026-02-18 | Savill Corrine |
Chief Business Officer | Award | 175,000 |
| 2026-02-18 | Michaelson Jennifer |
Chief Scientific Officer | Award | 115,000 |
| 2026-02-18 | Jones Jeffrey Alan |
Chief Medical Officer | Award | 300,000 |
| 2026-02-18 | SUMER JACQUELYN L |
Chief Legal Officer | Award | 230,000 |
| 2026-02-18 | Fenton Mary Kay |
Chief Financial Officer | Award | 68,750 |
| 2026-02-18 | Michaelson Jennifer |
Chief Scientific Officer | Award | 57,500 |
| 2026-02-18 | Fenton Mary Kay |
Chief Financial Officer | Award | 137,500 |
| 2026-02-18 | AHMED NADIM |
EVP and President, Hematology | Award | 828,000 |
| 2026-02-12 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 416 |
| 2026-01-22 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 4,000 |
| 2025-12-31 | Fenton Mary Kay |
Chief Financial Officer | Award | 27 |
| 2025-12-23 | AHMED NADIM |
EVP and President, Hematology | Sell | 9,922 |
| 2025-12-19 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 1,345 |
| 2025-12-18 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 2,898 |
| 2025-12-18 | SUMER JACQUELYN L |
Chief Legal Officer | Sell | 3,480 |
| 2025-12-18 | Jones Jeffrey Alan |
Chief Medical Officer | Sell | 4,632 |
| 2025-12-15 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 995 |
| 2025-12-12 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 2,148 |
| 2025-11-24 | Michaelson Jennifer |
Chief Scientific Officer | Sell | 4,000 |
| 2025-10-28 | Lynx1 Capital Management LP |
10% Owner | Buy | 165,667 |
| 2025-10-17 | Lynx1 Capital Management LP |
10% Owner | Buy | 32,217 |
| 2025-10-16 | Lynx1 Capital Management LP |
10% Owner | Buy | 150,000 |
| 2025-10-15 | Lynx1 Capital Management LP |
10% Owner | Buy | 51,500 |
Showing 1–50 of 432 transactions